Three Seasons Wealth, LLC Novo Nordisk A S Transaction History

Three Seasons Wealth, LLC

  • $1.01 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$85.0 - $120.04 $321,555 - $454,111
3,783 New
3,783 $325 Million
Q3 2024

Apr 04, 2025
BUY
$119.07 - $145.42 $52,628 - $64,275
442 Added 12.1%
4,096 $488 Million
Q2 2024

Apr 04, 2025
SELL
$122.71 - $146.91 $15,829 - $18,951
-129 Reduced 3.41%
3,654 $522 Million

Others Institutions Holding NVO

# of Institutions
1,686
Shares Held
303M
Call Options Held
25.9M
Put Options Held
43.8M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Three Seasons Wealth, LLC Portfolio

Follow Three Seasons Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Three Seasons Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Three Seasons Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email